WeVote
Log In

Bill

Bill

SB 6183

Concerning coverage for HIV antiviral drugs.

2025-2026 Regular Session Introduced by Jess Bateman and 11 co-sponsors

Washington bill mandates health insurance coverage for HIV antiviral medications to improve treatment access and prevent transmission.

Delivered to Governor.
0
WeVote Research Nonpartisan
Bill Summary · SB 6183

Legislative bill overview

SB 6183 addresses insurance coverage requirements for HIV antiviral medications in Washington State. The bill appears to mandate or clarify health insurance coverage standards for antiretroviral drugs used to treat or prevent HIV infection. The first substitute indicates the original language was revised before advancing through the legislative process.

Why is this important

HIV treatment access directly affects public health outcomes and individual health equity. Clear insurance coverage requirements ensure patients can afford medications like PrEP (pre-exposure prophylaxis) and antiretroviral therapy, which are highly effective at preventing transmission and managing the disease. This impacts both healthcare costs and HIV prevention efforts statewide.

Potential points of contention

  • Coverage mandate scope: Disagreement over which specific drugs, dosages, or patient populations must be covered, and whether insurers can impose prior authorization or copay limitations
  • Cost and premium impact: Concerns from insurers and employers about increased premiums versus advocates' arguments that prevention saves long-term healthcare costs
  • Implementation details: Questions about whether coverage applies to all insurance plans equally (commercial, Medicaid, etc.) and what compliance mechanisms exist

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.